Study finds NHS breast cancer checks miss up to 95% of high‑risk women under 50

Researchers have warned that the National Health Service’s current breast‑cancer screening programme fails to identify the majority of younger women who are at heightened risk of the disease, with recent analysis suggesting that as many as 95 percent of this group are overlooked. The study, conducted by a team of oncologists and epidemiologists, examined NHS screening criteria, which traditionally begin routine mammography at age 50, and compared them with risk‑assessment models that factor in family history, genetic markers and lifestyle variables for women under 50. The researchers found that the existing age‑based approach excludes most high‑risk women in their 30s and 40s, a demographic that, while representing a smaller proportion of overall cases, experiences more aggressive tumor types and poorer outcomes when diagnosis is delayed.

The findings highlight a gap between population‑wide screening policies and individualized risk evaluation, prompting calls for the NHS to integrate more comprehensive risk‑stratification tools into its preventive services. Health officials have acknowledged the need to balance resource allocation with early detection benefits and indicated that pilot programmes incorporating genetic testing and tailored imaging schedules are under review. If adopted, such measures could expand access to earlier diagnostic interventions for younger high‑risk patients, potentially improving survival rates and reducing the burden of advanced breast cancer within this underserved group.